Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In metabolic diseases, under the Boehringer/Lilly alliance, the FDA approved Synjardy (empagliflozin and metformin hydrochloride) tablets for the treatment of type 2 diabetes
Blood Sugar Control : Significant reductions in HbA1c levels were observed, indicating better blood sugar management
According to Research and Markets, the global GLP-1 market is estimated to grow from $62.2 billion to $157.5 billion by 2035, at a CAGR of 9.7%
The most commonly reported adverse events were gastrointestinal, including: Nausea Vomiting Diarrhea GI discomfort Higher doses generally produced stronger effects but also higher dropout rates
To enforce food restrictions, caregivers often use physical barriers such as locking food cupboards and refrigerators and providing close supervision
US$ 24.75
US$ 27.75
US$ 23.91
